New hope for rare cancer: virus-based therapy combined with immunotherapy
Disease control
Ongoing
This study tests a new treatment for angiosarcoma, a rare and aggressive cancer of the blood vessels. The treatment combines a virus that is injected directly into tumors (vusolimogene oderparepvec) with an immunotherapy drug (pembrolizumab). The goal is to see if this combinatio…
Phase: PHASE2 • Sponsor: Varun Monga, MBBS • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC